NR4A1 and breast cancer: We excluded also the possibility of a late recurrence of the primary BC because of the lack of MEC elements, the strong hormone receptor expression in 1996, and the presence of an in situ component with MEC features in the current tumor, supporting the diagnosis of a second primary.